Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | KDR | P35968 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | AURKA | O14965 | 1/20 | 0.46 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.46 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Kinetin SCHEMBL23818 | 0.93 | SMN1; SMN2 (0.54) | SMN1; SMN2HIF1AMEN1TP53CYP1A2 | |
| Kinetin SCHEMBL458140 | 0.93 | SMN1; SMN2 (0.54) | SMN1; SMN2HIF1AMEN1TP53CYP1A2 | |
| Kinetin SCHEMBL9811831 | 0.92 | SMN1; SMN2 (0.47) | SMN1; SMN2HIF1AMEN1TP53CYP1A2 | |
| Kinetin SCHEMBL9125232 | 0.92 | SMN1; SMN2 (0.53) | SMN1; SMN2HIF1AMEN1TP53CYP1A2 | |
| Kinetin SCHEMBL584400 | 0.92 | SMN1; SMN2 (0.53) | SMN1; SMN2HIF1AMEN1TP53CYP1A2 | |
| Kinetin SCHEMBL11692724 | 0.91 | SMN1; SMN2 (0.48) | SMN1; SMN2HIF1AMEN1TP53CYP1A2 | |
| Kinetin SCHEMBL15941490 | 0.91 | SMN1; SMN2 (0.48) | SMN1; SMN2HIF1AMEN1TP53CYP1A2 | |
| Kinetin SCHEMBL2136943 | 0.90 | SMN1; SMN2 (0.42) | SMN1; SMN2HIF1AMEN1TP53CYP1A2 | |
| 6-Benzylaminopurine SCHEMBL1708008 | 0.86 | SMN1; SMN2 (0.48) | SMN1; SMN2HIF1AMEN1TP53CYP1A2 | |
| Kinetin SCHEMBL14576216 | 0.86 | SMN1; SMN2 (0.48) | SMN1; SMN2HIF1AMEN1TP53CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4131025-A | — | — | None | — | — | JP | disclosed |
| CN-116671437-A | Acer truncatum culture medium and application thereof | 北京市园林绿化科学研究院 | 2023-09-01 | — | — | CN | disclosed |
| EP-2100507-B1 | QUINAZOLINE DERIVATIVES CAPABLE OF INHIBITING CYTOKININ SIGNALING | SUMITOMO CHEMICAL CO (JP) | 2015-02-25 | — | — | EP | disclosed |
| US-8722580-B2 | Agent for inhibiting cytokinin signaling | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-05-13 | — | — | US | disclosed |
| US-20100056377-A1 | AGENT FOR INHIBITING CYTOKININ SIGNALING | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-03-04 | — | — | US | disclosed |
| EP-2100507-A1 | SUBSTANCE CAPABLE OF INHIBITING CYTOKININ SIGNALING | Sumitomo Chemical Company, Limited (JP) | 2009-09-16 | — | — | EP | disclosed |
| US-6323394-B1 | Tissue culture process for producing a large number of viable mint plants in vitro | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2001-11-27 | — | — | US | disclosed |
| US-5898001-A | Tissue culture process for producing a large number of viable mint plants in vitro from internodal segments | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 1999-04-27 | — | — | US | disclosed |
| JP-H04131025-A | PRODUCTION OF SEEDLESS WATERMELON USING PLANT HORMONE | HAYATA YASUYOSHI | 1992-05-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100056377-A1 | AGENT FOR INHIBITING CYTOKININ SIGNALING | CROCC, STAT3, GRK6 | SMN1; SMN2 4884/4885HIF1A 2545/4885MEN1 3850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.